Hem

Press release from Companies

Publicerat: 2022-11-18 16:45:09

Cessatech A/S: CESSATECH ANNOUNCES LAST DAY OF TRADING IN BTU AND THE FIRST DAY OF TRADING IN WARRANTS OF SERIES TO2

København, Denmark, November 18, 2022 – The rights issue announced on October 19, 2022 in Cessatech A/S has been registered with the Danish Companies Office (Dk: "Erhvervsstyrelsen") and paid subscribed units (BTU) will be replaced by shares and warrants of series TO2.

The last day of trading in BTU is November 22, 2022. The first day of trading with new shares and warrants is November 23, 2002. Trades from the 23rd and onwards will be settled in the new ISIN codes. The warrants will be traded under ISIN code DK0061926888. The new shares and warrants will appear on the investors accounts from November 25, 2022.

For more information about Cessatech, please contact:
Jes Trygved, CEO
Phone: +45 9387 2309
E-mail: jes.trygved@cessatech.com
www.cessatech.com

About Cessatech
Cessatech A/S is a Danish pharmaceutical company committed to developing and commercialising evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. The advantages include needle-free administration, being easy to administer, a fast-acting therapeutic effect, and being medically approved for children. CT001 is at its pivotal stage of clinical development.

Läs mer hos Cision
Läs mer om Cessatech A/S

Prenumeration